Growth Hormone & Igf Research

Papers
(The median citation count of Growth Hormone & Igf Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Impact of short stature on quality of life: A systematic literature review28
Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology24
The effect of combined functional training on BDNF, IGF-1, and their association with health-related fitness in the multiple sclerosis women16
Pregnancy-associated plasma proteins and Stanniocalcin-2 – Novel players controlling IGF-I physiology15
Treatment of the adult growth hormone deficiency syndrome with growth hormone: What are the implications for other hormone replacement therapies for hypopituitarism?11
Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood10
Bioactive growth hormone in humans: Controversies, complexities and concepts10
Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity10
Effects of a home-based exercise program on the insulin-like growth factor axis in patients operated for colorectal cancer in Sweden: Results from the randomised controlled trial PHYSSURG-C9
Digital technologies to improve the precision of paediatric growth disorder diagnosis and management9
Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study9
Molecular and cellular effects of insulin-like growth factor-1 and LongR3-IGF-1 on in vitro maturation of bovine oocytes: comparative study9
Economic and clinical burden of comorbidities among patients with acromegaly9
Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observa8
Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants8
Growth hormone replacement in adults: Real-world data from two large studies in US and Europe8
Tissue-specific disruption of the growth hormone receptor (GHR) in mice: An update7
The IGF system and longitudinal growth in preterm infants in relation to gestational age, birth weight and gender7
Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly7
The combined frequencies of the IL-6 G-174C and IGFBP3 A-202C polymorphisms among swimmers and runners7
Potential applications for rhIGF-I: Bone disease and IGF I7
Hormonal stress responses of growth hormone and insulin-like growth factor-I in highly resistance trained women and men7
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis7
Growth hormone increases dendritic spine density in primary hippocampal cell cultures7
Mechanisms of putative IGF-I receptor resistance in active acromegaly7
Linkage between growth retardation and pituitary cell morphology in a dystrophin-deficient pig model of Duchenne muscular dystrophy6
Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services6
Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue6
Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children6
A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury6
Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in p6
Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis6
Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency6
Endoplasmic reticulum stress induces growth retardation by inhibiting growth hormone IGF-I axis6
Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas6
A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI)6
Analyzing structural differences between insulin receptor (IR) and IGF1R for designing small molecule allosteric inhibitors of IGF1R as novel anti-cancer agents5
Testing for growth hormone deficiency in children5
p.R209H GH1 variant challenges short stature assessment5
Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center5
Childhood growth hormone deficiency, a diagnosis in evolution: The intersection of growth hormone history and ethics5
Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients5
Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 cases5
Dental arches in inherited severe isolated growth hormone deficiency4
Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study4
Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency4
The involvement of Sestrin2 in the effect of IGF-I and leucine on mTROC1 activity in C2C12 and L6 myocytes4
Effects of high-dose all-trans retinoic acid on longitudinal bone growth of young rats4
The effect of milk and rapeseed protein on growth factors in 7–8 year-old healthy children – A randomized controlled trial4
From dwarves to giants: South American's contribution to the history of growth hormone and related disorders4
Personality traits in acromegalic patients: Comparison with patients with non-functioning adenomas and healthy controls3
Course and outcomes of pregnancy in women treated for acromegaly: Discerning a contemporary cohort3
Growth of teeth and bones in adult subjects with congenital untreated isolated growth hormone deficiency3
Growth hormone modulates Trypanosoma cruzi infection in vitro3
Nicotine inhibits expression of Prrx1 in pituitary stem/progenitor cells through epigenetic regulation, leading to a delayed supply of growth-hormone-producing cells3
The association between treatment and systemic inflammation in acromegaly3
Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly3
Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature3
Growth hormone secreting pituitary carcinomas: Case report and review of literature3
Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum3
Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients3
Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder3
Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression3
Prevalence and predictors of abnormal glucose tolerance and its resolution in acromegaly: Single Centre retrospective study of 90 cases2
Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly?2
Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients2
The acromegaly registry of ten different centers in Turkey2
Cardiac functions in children with growth hormone deficiency: Effects of one year of GH replacement therapy2
A common deletion in the growth hormone receptor gene (d3-GHR) in the offspring is related to maternal placental GH levels during pregnancy2
Effects of raloxifene administration on serum levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein 3 levels: A systematic review and meta-analysis of randomized contro2
Acromegaly-related cutis verticis gyrata2
Pulse wave velocity is decreased in acromegaly compared to non-acromegaly study participants with similar cardiovascular risk profile2
A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I)2
A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly2
The significance of estrogen receptors in acromegaly: Are they useful as predictors of prognosis and therapy regimen?2
Growth hormone responses during arginine and clonidine stimulation test: Correlations with patients' auxological and metabolic parameters in a single centre study2
Biomarkers of growth and carbohydrate metabolism in neonatal rats supplemented with fish oil and/or antioxidants during intermittent hypoxia2
IGF-1 knockdown inhibits phosphorylation of Akt and ERK in chicken embryonic myotubes2
Endothelial dysfunction in patients with acromegaly and It's association with Endocan2
Efficacy and safety of growth hormone therapy in children with Noonan syndrome2
In missed abortion the decrease of IGF-1 down-regulates PI3K/AKT signaling pathway reducing the secretion of progesterone and β-hCG2
GHRH expression plasmid improves osteoporosis and skin damage in aged mice2
Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failure1
Assessing insulin sensitivity and resistance in syndromes of severe short stature1
“Subclinical atherosclerosis in acromegaly: Possible association with cardiovascular risk factors rather than disease activity”1
Effect of long-acting growth hormone treatment on endogenous growth hormone secretion in prepubertal patients with idiopathic short stature: A preliminary study1
Clinical and epidemiological characteristics, morbidity and treatment based on the registry of acromegalic patients in Colombia: RAPACO1
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.1
Changes in anterior segment parameters and presence of dry eye disease in patients with acromegaly: A Sirius topography study combined with meibography1
Recovery using “float” from high intensity stress on growth hormone-like molecules in resistance trained men1
The necessity of magnetic resonance imaging in the evaluation of pediatric growth hormone deficiency: Lessons from a large academic center1
Liver and muscle-specific effects of phoenixin-20 on the insulin-like growth factor system mRNAs in zebrafish1
Effects of 18 months of GH replacement on cardiovascular risk factors and quality of life in GH deficient adults; a randomized controlled trial using a fixed very low and a standard dose of GH1
The inter – Test variability of growth hormone stimulation tests and factors affecting this variability1
Role of growth hormone signaling pathways in the development of atherosclerosis1
The prevalence of IGF-I axis genetic polymorphisms among decathlon athletes1
Lacrimal gland enlargement and tear film changes in acromegaly patients: A controlled study1
Increase of serum lipoprotein (a), an adverse effect of growth hormone treatment1
Association between insulin-like growth factor 1 and pancreatic volume in type 1 and type 2 diabetes: cross-sectional study of a Japanese population1
Effect of amino acids on IGF1 gene expression in human myotubes and skeletal muscle1
Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study1
Effect of a copper intrauterine device on HLA-G and IGF-II levels during pregnancy1
Relationship between circulating insulin-like growth factor-1 and blood pressure in adults: A systematic review and meta-analysis of observational studies1
Time course and reaction types of serum IGF-1 and its relationship to BMI and leptin regarding inpatients with anorexia nervosa1
Comparison of growth response and adverse reaction according to growth hormone dosing strategy for children with short stature: LG Growth Study1
Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment – A pilot study1
Growth hormone-releasing hormone antagonists counteract hydrogen peroxide – induced paracellular hyperpermeability in endothelial cells1
0.023676872253418